| Date Filed | Type | Description |
| 06/09/2023 |
4
| Simon Barry J. (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2022 |
4
| Simon Barry J. (Director) has filed a Form 4 on ImmunityBio, Inc.|
Txns:
| Granted 10,714 options to buy
@ $5.83, valued at
$62.5k
|
|
| 01/28/2022 |
5
| Simon Barry J. (Director) has filed a Form 5 on ImmunityBio, Inc. |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Sold 36,626 shares
@ $20.6123, valued at
$754.9k
Sold 11,304 shares
@ $20.5344, valued at
$232.1k
Exercised 36,626 options to buy
@ $1.9984, valued at
$73.2k
Exercised 11,304 options to buy
@ $1.9984, valued at
$22.6k
|
|
| 01/06/2021 |
4
| Simon Barry J. (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $12.36, valued at
$123.6k
|
|
| 12/28/2020 |
4
| Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Sold 130,000 shares
@ $18.0508, valued at
$2.3M
Exercised 130,000 options to buy
@ $1.9984, valued at
$259.8k
|
|
| 07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Sold 13,737 shares
@ $9.0003, valued at
$123.6k
Sold 66,263 shares
@ $9.4292, valued at
$624.8k
Sold 80,000 shares
@ $10.5458, valued at
$843.7k
Sold 10,432 shares
@ $13.0089, valued at
$135.7k
Sold 29,609 shares
@ $13.0073, valued at
$385.1k
Exercised 9,337 options to buy
@ $1.7554, valued at
$16.4k
Exercised 136,729 options to buy
@ $1.7554, valued at
$240k
Exercised 29,609 options to buy
@ $1.7554, valued at
$52k
|
|
| 05/29/2020 |
4
| Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Sold 75,000 shares
@ $7.5645, valued at
$567.3k
|
|
| 05/22/2020 |
4
| Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Sold 36,932 shares
@ $5.5155, valued at
$203.7k
|
|
| 05/13/2020 |
4
| Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Sold 28,068 shares
@ $5.5048, valued at
$154.5k
|
|
| 01/06/2020 |
4
| Simon Barry J. (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 9,600 options to buy
@ $16.31, valued at
$156.6k
|
|
| 01/03/2019 |
4
| Simon Barry J. (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 9,600 options to buy
@ $5.16, valued at
$49.5k
|
|
| 08/29/2018 |
4
| Simon Barry J. (See remarks) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Granted 200,000 options to buy
@ $3.07, valued at
$614k
|
|
| 06/14/2018 |
4
| Simon Barry J. (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Exercised 8,000 options to buy
@ $14.24, valued at
$113.9k
|
|
| 02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/27/2017 |
3
| Simon Barry J. (Director) has filed a Form 3 on Cue Biopharma, Inc. |
| 09/09/2016 |
4
| Simon Barry J. (President and COO) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Sold 2,000 shares
@ $8.8356, valued at
$17.7k
Sold 30,000 shares
@ $7.4, valued at
$222k
|
|
| 07/28/2016 |
4
| Simon Barry J. (President and COO) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Paid exercise price by delivering 79,322 shares
@ $6.89, valued at
$546.5k
Exercised 185,150 restricted stock units
@ $0 |
|